Several studies have shown that the expression of MEG3 is repressed in CSCs or cancer tissues, indicating that MEG3 may have inhibitory effects on cancer stemness, at least in the liver, head and neck, and lung cancers. Here, MEG3 is linked to lung carcinoma.